- Investing Ideas
- /
- Bangladeshi Pharmaceuticals & Biotech Undervalued based on future growth
Bangladeshi Pharmaceuticals & Biotech Undervalued based on future growth
Results
1
0 new
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
1 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
SQURPHARMA | ৳216.60 | -2.8% | 3.0% | ৳192.0b | ৳319.47 | PE9.1x | E12.9% | 5.1% |
Page 1 of 1